Vimarsana
Biggest News Aggregation in the World

Page 4 - Allogeneic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Allogeneic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Allogeneic Today - Breaking & Trending Today

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Vimarsana News

Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on May 31,... | May 31, 2023

Tessa Therapeutics Ltd: Tessa Therapeutics' Autologous and Allogeneic Cell Therapy Data to be Featured at the 17th International Conference on Malignant Lymphoma, Lugano - Vimarsana News

Tessa Therapeutics Ltd: Tessa Therapeutics' Autologous and Allogeneic Cell Therapy Data to be Featured at the 17th International Conference on Malignant Lymphoma, Lugano

New data from clinical trials of TT11 and TT11X to be featured in oral and poster presentationsSINGAPORE, May 30, 2023 (Tessa), a clinical-stage cell therapy company developing next-generation cancer treatments

Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences - Vimarsana News

Allogene Therapeutics Announces Participation in Three Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., May 24, 2023 -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T products for cancer, today... | May 24, 2023

Precision BioSciences to Participate in Upcoming Stifel Genetic Medicines Day - Vimarsana News

Precision BioSciences to Participate in Upcoming Stifel Genetic Medicines Day

Precision BioSciences, Inc. a clinical stage gene editing company developing ARCUS®-based in vivo gene editing and ex vivo allogeneic CAR T therapies, today announced that the Company will... | May 24, 2023

Lineage Cell Therapeutics Expected to Be Added to Russell 3000® Index - Vimarsana News

Lineage Cell Therapeutics Expected to Be Added to Russell 3000® Index

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today reported that the Company is expected to be added to the... | May 22, 2023